Skip to Content
  • Proceeding Paper
  • Open Access

28 August 2026

24 Pages

Network Pharmacology-Based Elucidation of Piperlongumine Action on Oncogenic Survival and Immune-Evasive Pathways in Pancreatic Cancer †

,
,
and
1
Department of Biology, Faculty of Natural Life Science, Earth and Universe Sciences, Mohamed Khider University, P.O. Box 145 RP, Biskra 07000, Algeria
2
Department of Oral and Maxillofacial Surgery, University of California, 707 Parnassus Ave Suite D-1201, San Francisco, CA 94143, USA
3
Laboratory of Biotechnology, National Higher School of Biotechnology, Constantine 25000, Algeria
*
Authors to whom correspondence should be addressed.

Abstract

Pancreatic cancer (PC) remains one of the most aggressive malignancies, largely due to late diagnosis, rapid metastatic progression, and the limited efficacy of current therapeutics. Piperlongumine, a bioactive alkaloid isolated from Piper longum, has attracted attention for its selective cytotoxicity toward cancer cells and its ability to modulate multiple oncogenic pathways. However, its molecular mechanisms in PC remain insufficiently understood. In this computational systems pharmacology study, a network pharmacology strategy combined with molecular docking was used to investigate the molecular targets and pathways associated with piperlongumine anticancer activity. Targets of piperlongumine and PC-related genes were retrieved from public databases and intersected to identify shared targets. Overlapping targets were used to construct a protein–protein interaction network using the STRING (v.12.0) platform. Hub genes were identified using the CytoHubba plugin using six topological algorithms. Functional enrichment analyses (Gene ontology and KEGG pathway) were performed using the ShinyGO 0.85.1 platform. Prognostic relevance of the hub targets was evaluated using Kaplan–Meier Plotter platform, while immune cell infiltration patterns were explored using the TIMER-2 database. Molecular docking was conducted using AutoDock Vina (1.5.7) to validate ligand-target interactions. A total of 237 intersecting genes were identified. Network analysis revealed several central hub genes, including TP53, Akt-1, STAT-3, CTNNB-1, IL-6, TNF-α, and Bcl-2. KEGG pathway analysis highlighted PC as the most enriched pathway, together with chronic myeloid leukemia, the AGE-RAGE signaling pathway in diabetic complications, prostate cancer, and C-type lectin receptor signaling. Survival analysis revealed significant prognostic associations for several hub genes, while TIMER analysis suggested correlations with tumor-associated immune cell infiltration. Molecular docking confirmed favorable binding affinities of piperlongumine toward key oncogenic targets, particularly Bcl-2 (−7.2 kcal/mol), TP53 (−6.2 kcal/mol), CTNNB-1 (−6.2 kcal/mol), and Akt-1 (−5.8 kcal/mol). Collectively, this study uncovers piperlongumine anticancer potential in PC, mediated through coordinated regulation of apoptosis, inflammatory, and immune pathways, highlighting its promise for future experimental and translational investigations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.